Tuesday, February 28, 2023

February 28, 2023 at 03:40PM Measles, Mumps and Rubella Virus Vaccine Live

Product approval information for the Measles, Mumps, and Rubella Virus Vaccine, Live also known as M-M-R II.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6YfyLgV

February 28, 2023 at 01:28PM KINRIX

Changes to your package insert to the Dosage and Administration section regarding visual inspection by the user for cracked vials or syringes prior to administration of the vaccine and non-use of product should those conditions exist.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/85AJm1k

Wednesday, February 22, 2023

February 22, 2023 at 07:35PM How do I request a Patient Listening Session?

Learn about how to request a Patient Listening Session with the FDA to share your experiences and perspectives.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/MbBvht0

February 22, 2023 at 07:26PM Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Office of Patient Affairs draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/0HgYyxh

Tuesday, February 21, 2023

February 21, 2023 at 11:06PM Adacel

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ow8eKuh

February 21, 2023 at 07:46PM Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays

Links to the different types of Donor Screening Assays. A table for each assay is provided with detailed information such as tradename, infectious agent, format, specimen, use, manufacturer, approval date, and STN.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tkpVRCq

February 21, 2023 at 05:07PM Jobs at the Center for Biologics Evaluation and Research (CBER)

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bx5HvIp

Friday, February 17, 2023

February 17, 2023 at 10:11PM Information for Practitioners - FDA’s Regulatory Oversight of Regenerative Medicine Products - 11/17/2022

The FDA’s Center for Biologics Evaluation and Research (CBER) is hosting a public webinar on November 17, 2022, at 11:00 am.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/T371hqQ

February 17, 2023 at 08:12PM Highlighting Major Issues Critical to FDA Across Our Diverse Agency After One Year Back

This week marks my one-year anniversary as the 25th Commissioner for Food and Drugs. I have been proud to represent the U.S. Food and Drug Administration and its talented and hard-working staff in these extraordinary times.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bs92GiX

Thursday, February 16, 2023

February 16, 2023 at 03:43PM Executive Order 13944 List of Essential Medicines, Medical Countermeasures, and Critical Inputs

In consultation with other federal partners, FDA has developed a list of drug and biological product essential medicines, drug, biological product, and device medical countermeasures, and critical inputs, as required by Executive Order 13944. FDA welcomes public comment on this list.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/lvkWZ1c

February 16, 2023 at 02:54PM Exceptions and Alternative Procedures Approved Under 21 CFR 640.120

Title 21 Code of Federal Regulations 640.120(a) - The Director, Center for Biologics Evaluation and Research, may approve an exception or alternative procedures to any requirement in subchapter F (Biologics) of Chapter I (Parts 600 - 680) of title 21 of the Code of Federal Regulations regarding bloo

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/NKxXDGf

Tuesday, February 14, 2023

February 14, 2023 at 10:55PM FAQs: What happens to EUAs when a public health emergency ends?

Answers to frequently asked questions about what happens to Emergency Use Authorizations (EUAs), and medical products available under EUA, when a public health emergency ends.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/IL48xAm

February 14, 2023 at 02:24AM Fluzone Quadrivalent, Fluzone High-Dose Quadrivalent, Fluzone, Intradermal Quadrivalent, Fluzone Quadrivalent Southern Hemisphere, Fluzone High-Dose Quadrivalent Southern Hemisphere

For active immunization of persons 6 months of age and older for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2HJwD51

Monday, February 13, 2023

February 13, 2023 at 10:45PM Moderna COVID-19 Vaccines

Information about Spikevax, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine, Bivalent. Updated COVID-19 vaccine boosters are now FDA-authorized.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7MpgWRz

February 13, 2023 at 09:52PM Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products - 04/27/2023

Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual public listening meeting to solicit input on methods and approaches (e.g., use of real-world evidence (RWE), registries) for capturing post approval safety and efficacy data for cell and gene therapy products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/gJtRS7r

February 13, 2023 at 09:08PM FDALabel: Full-Text Search of Drug Product Labeling

FDALabel Database is a web-based application that allows users to perform customizable searches of a database containing over 140,000 labeling documents for FDA-approved drug products, including human and animal prescription and over-the-counter drugs, biological products, and medical devices.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/0DY6iAP

February 13, 2023 at 08:01PM VAXCHORA

VAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/gHWuKzQ

February 13, 2023 at 02:50PM Vaccine Safety & Availability

Vaccine Safety & Availability

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bnt2Fu9

Thursday, February 9, 2023

February 09, 2023 at 09:57PM Blood Grouping and Phenotyping Reagents

Blood Grouping and Phenotyping Reagents Main Page listed in alphabetical order by manufacturer, then by product

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tzaZGM7

February 09, 2023 at 07:24PM CBER Reports

This page contains a summary of regulatory, research, and administrative accomplishments for the last 2 fiscal years and related reports.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/wv9rukP

Wednesday, February 8, 2023

February 08, 2023 at 11:25PM HIV Home Test Kits

Information and Links related to HIV Testing questions and answers are also provided.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vmVZCAl

February 08, 2023 at 10:04PM 2009 H1N1 (Swine) Flu Virus (Biologics)

CBER's Vaccine and Blood Teams are working to facilitate the availability of safe and effective vaccines and ensuring that the blood supply is not affected by the H1N1 Flu Virus.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tiZf26g

Tuesday, February 7, 2023

February 07, 2023 at 11:23PM CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19

CDER Scientific Reviews Supporting EUA for Therapeutic Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/34g9Pr7

February 07, 2023 at 08:53PM Gardasil

Product approval information for Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant also known as Gardasil.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/adFUXHT

February 07, 2023 at 08:45PM Drugs@FDA Data Files

Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tz0DTwb

Monday, February 6, 2023

February 07, 2023 at 12:35AM Pandemic Influenza Information

Pandemic influenza (flu) is a significant global public health threat. Preparedness has been recognized as a critical local, national and worldwide priority

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/wnRh7KU

February 07, 2023 at 12:08AM Questions about Vaccines

Information on general and specific vaccines

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XSDJ5QT

February 06, 2023 at 11:59PM Tissue & Tissue Products

CBER regulates human cells or tissue intended for implantation, transplantation, infusion, or transfer into a human recipient is regulated as a human cell, tissue, and cellular and tissue-based product or HCT/P.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/P6VpsHJ

February 06, 2023 at 08:45PM Cellular & Gene Therapy Guidances

This page contains a listing of cellular and gene therapy guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/IxQhcAn

February 06, 2023 at 02:32PM Immune Globulins

Lists of immune globulins fractionated plasma products blood.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/kx23GB4

February 03, 2023 at 08:55PM Workshops, Meetings & Conferences (Biologics)

Information on CBER sponsored or co-sponsored meetings, conferences and workshops about various biologics in order to educate the public and seek the opinion of interested parties.

via Whats New Vaccines Blood Biologics RSS Feed http://www.fda.gov/vaccines-blood-biologics/news-events-biologics/workshops-meetings-conferences-biologics

February 03, 2023 at 05:59PM CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19

CDER Scientific Reviews Supporting EUA for Therapeutic Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/K1UolO7

Wednesday, February 1, 2023

February 01, 2023 at 09:18PM Administrative Guidances

This page lists Administrative Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/g5tNu36

February 01, 2023 at 05:05PM Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Office of Patient Affairs draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/DnvbOHL